TARRYTOWN, N.Y., April 29, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows:
- Bank of America Merrill Lynch Healthcare Conference at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Tuesday, May 10, 2016
- Barclays 2016 Biopharmaceuticals CEO/CFO Conference Call Series at 11:00 a.m. Eastern Time on Thursday, May 19, 2016
The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-2016-investor-conference-presentations-300259810.html
SOURCE Regeneron Pharmaceuticals, Inc.